Loading company
Biofrontera Inc.
BFRI · Nasdaq · ·
Next earnings: November 11, 2026
$1.09-4.0%Sep 29 close
- 1M
- -31.4%
- 6M
- +39.9%
- 1Y
- +10.7%
BFRI · Nasdaq · ·
Next earnings: November 11, 2026
$1.09-4.0%Sep 29 close
Biofrontera Inc. is scheduled to report next on November 11, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $12M | $9M | +32.92% |
| Profit | -$604K | -$5.3M | +88.66% |
| Profit per share | -$0.05 | -$0.57 | +91.23% |
| Free Cash Flow | -$1.7M | -$3M | +45.57% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“We see positive effects from the Strategic Transaction and our overall cost management, the impacts of which are now visible in the Q2 results,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with photodynamic therapy (PDT). The Company’s products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, and in development for additional indications.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Biofrontera Inc.’s Item 2.02 8-K filed August 13, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Biofrontera Inc. has no earnings call transcript available.